Information for Researchers
The Research Center at Swedish exists to provide support for the needs of investigators performing research endeavors that impact Swedish staff, patients and resources. The center provides administrative and financial oversight to ensure that investigations meet the safety, ethical, and financial standards of the research milieu.
The Swedish Institutional Review Office provides guidance and information regarding new study initiation which is accessible through the internet. Information about starting a research study can also be accessed through our internal Research Center intranet site. Visitors who have access to our intranet pages may wish to visit these pages:
Swedish Scientific Showcase
In addition to their clinical excellence, Swedish medical professionals conduct ground breaking research and publish in key scientific journals. We want to shine light on these accomplishments in increasing medical knowledge and improving patient care.
We cannot honor what we do not know. When your papers are accepted for conferences and publication, send the citation to ACCOLADES (email@example.com) and we will highlight them in our monthly board report and other venues including our webpage and annual report. Please send us your publication information so we can give your hard work the recognition and respect it deserves.
Research paper published in Annals of Hepatology by members of 'Liver Care Network and Organ Transplant Program, Swedish Medical Center, Seattle, WA, USA'. 'Epidemiologic features of a large hepatitis C cohort evaluated in a major health system in the western United States' was published in Annals of Hepatology Volume 18, Issue 2, March–April 2019. The authors are: Nizar A. Mukhtar, Erik M. Ness, Manan Jhaveri, Oren K., Marquis Hart, Christopher Dale, Cheryl Pratt, Kris V. Kowdley.
Dr. Saul Rivkin, MD, et al, has recently had this paper published in the International Journal of Gynecological Cancer. Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients. Saul Eugene Rivkin,1,2 James Moon,3 Desiree S Iriarte,1 Erik Bailey,1 Heather L Sloan,1 Gary E Goodman,1 Amy E BonDurant,4 Dan Velijovich,4 Tanya Wahl,1 Peter Jiang,5 Chirag A Shah,4 Charles Drescher,4 Mehmet F Fer,1 Henry G Kaplan,1 Erin D Ellis1.
1 Swedish Cancert Institute, Seattle, Washington, USA
2 Marsha Rivkin Center for Ovarian Cancer Research, Seattle, Washington, USA
3 Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
4 Pacific Gynecology Specialists, Seattle, Washington, USA
5 Providence Regional Cancer Partnership Everett Clinic,Everett, Washington, USA.
Jorge A. Castellanos MD, Fellow at the Swedish Heart & Vascular Institute has published Returning to Fellowship for Formal Structural Heart Training After Being in Clinical Practice: Challenges and Advantages -
Philip J. Mease, MD
Jorge A. Castellanos (2019): Returning to Fellowship for Formal Structural Heart Training After Being in Clinical Practice: Challenges and Advantages, Structural Heart, DOI: 10.1080/24748706.2019.1576953
, Research Investigator at Swedish Medical Center has published two articles in The Lancet and one article in the New England Journal of Medicine during October 2018:
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
Mease P1, Coates LC2, Helliwell PS3, Stanislavchuk M4, Rychlewska-Hanczewska A5, Dudek A6, Abi-Saab W7, Tasset C7, Meuleners L7, Harrison P7, Besuyen R8, Van der Aa A7, Mozaffarian N9, Greer JM9, Kunder R9, Van den Bosch F10, Gladman DD11. Was published in The Lancet: 2018 Oct 22. pii: S0140-6736(18)32483-8. doi: 10.1016/S0140-6736(18)32483-8.
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D1, Cheng-Chung Wei J2, Dougados M3, Mease P4, Deodhar A5, Maksymowych WP6, Van den Bosch F7, Sieper J8, Tomita T9, Landewé R10, Zhao F11, Krishnan E11, Adams DH11, Pangallo B11, Carlier H11; COAST-V study group. Was published in The Lancet: 2018 Oct 22. pii: S0140-6736(18)31946-9. doi: 10.1016/S0140-6736(18)31946-9.
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
Mease P1, Hall S1, FitzGerald O1, van der Heijde D1, Merola JF1, Avila-Zapata F1, Cieślak D1, Graham D1, Wang C1, Menon S1, Hendrikx T1, Kanik KS1. Was published in the New England Journal of Medicine 2017 Oct 19;377(16):1537-1550. doi: 10.1056/NEJMoa1615975.
WCLC study: Women with non-small cell lung cancers live longer than men.
Swedish Research Investigator Eric Vallieres, MD (Physician Surgeon, Swedish Thoracic Surgery Clinic) participated in this study which was presented at the International Association for the Study of Lung Cancer's (IASLC's) 19th World Conference on Lung Cancer (WCLC) in Toronto, Ontario, Canada.
Swedish Neuroscience - Research Presentation:
Poster to be presented at NEALS Consortium.
Swedish Heart & Vascular Institute - Research Publications:
View list of research publications.
Swedish Neuroscience Fellows' Research Publications:
View list of research publications.
Swedish Research Scientist Darryl S.Wells, MD is an author on a paper recently published in the European Heart Journal: Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
Group Health Research Institute scientific seminars.
The seminars are usually held the second and fourth Thursday of each month from 4-5 pm at Metropolitan Park East, 1730 Minor Ave, room 1509A. View seminar schedule.
Swedish Research Scientist Smita Nayak, MD is an author on a paper recently published in the journal Public Health Reports. Dr. Nayak is quoted in this news article.
Presented at SNO Scientific Meeting, November 22nd 2015: "An anatomic transcriptional atlas of glioblastoma."
Puchalski R* , Shah N*, Miller J, Dalley R, Nomura S, Yoon J, Lankerovich M, Feng X, Long F, Bernard A, Ng L, Lein E, Phillips J, Dang C, Rostad S, Keogh B, Farrokhi F, Cobbs C, Hawrylycz M, Foltz G. *Co-presenters
Philip J. Mease, MD is the lead author for a research paper which was published in the New England Journal of Medicine on October 1, 2015. The article is entitled ‘Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis’. Read Article
Dr. Kris Kowdley , MD, FAASLD, Director of the Liver Care Network and Organ Care Research at Swedish Medical Center had the honor to present his research at the Presidential Plenary Clinical Session at AASLD, November 16, 2015.
Abstract title: "Efficacy and safety of vitamin E in nonalcoholic steatohepatitis patients with and without diabetes: Pooled analysis from the PIVENS and FLINT NIDDK NASH CRN trials."
Swedish Researchers Alexandra Parbery-Clark Au.D/Ph.D. and Douglas Backous M.D. presented this poster at the 2015 AAO0-HNSF Annual meeting in Dallas, TX
Swedish Researcher Cong Yu, MD publishes study in the Journal of the American Society of Anesthesiologists.
View Study Abstract.
Swedish Researcher Jey-Hsin Chen MD, PHD presents work at annual USCAP meeting.
The study evaluates the histopathology and clinical outcomes of patients with surgically resected pancreatic ductal carcinoma and variants that involve the peritoneum. The poster is available at this link.
Research conducted at Swedish Addiction Recovery Service presented at American Society of Addiction Medicine annual meeting: Swedish Addiction Recovery Service presented this poster at the national American Society of Addiction Medicine annual meeting, April 10-13. G. Rudolf, J. Walsh, A. Plawman, P. Gianutsos, W. Alto, L. Mancl, V. Rudolf. (Principal Investigator: Vania Rudolf.)
Research conducted at the Swedish Neuroscience Institute is featured in two recently published articles:
Jiang, H., D. Hua, J. Zhang, Q. Lan, Q. Huang, J. Yoon, X. Han, L. Li, G. Foltz, S. Zheng and B. Lin (2014). "MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting tumor suppressor gene SEPT7" Oncol Rep in press.
Jiang, H., C. Jin, J. Liu, D. Hua, F. Zhou, X. Lou, N. Zhao, Q. Lan, Q. Huang, J. G. Yoon, S. Zheng and B. Lin (2014). "Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-beta Signaling by Targeting SKI." OMICS in press.
Please note the recent publication by lead author Nameeta Shah, research scientist at The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute. The research article is: Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data. Nameeta Shah, Michael Lankerovich, Hwahyung Lee, Jae-Geun Yoon, Brett Schroeder and Greg Foltz (December 2013)
The Swedish Neuroscience Institute is featured in the 'Medical Innovations' article which was published in Alaska Airlines Magazine (November 2013).
Swedish Research Scientists (led by Neurosurgeon Stephen J. Monteith, MD) published in New England Journal of Medicine: A Pilot Study of Focused Ultrasound Thalamotomy for Essential Tremor. August 15, 2013.
Henry G. Kaplan, MD, and Judith A. Malmgren, PhD. Published "Ideas and Opinions" article:
The Breast Cancer Overdiagnosis Conundrum: An Oncologist's Viewpoint.
American College of Physicians: Annals of Internal Medicine
1 January 2013 | Volume 158 Number 1
Link to article
Link to pdf copy
Finding Full-Text Articles: Locating journal articles in the Swedish environment. (Presented to Swedish Investigator Forum by Mike Scully, Library Services - February 28th, 2012.)